VC-backed SI-BONE goes public
Santa Clara, California-based SI-BONE Inc, a medical device company, has debuted its IPO after pricing its 7.2 million shares at $15 per share. The stock began trading October 17, 2018 on the NASDAQ under the ticker symbol "SIBN." Morgan Stanley and BofA Merrill Lynch are the lead underwriters. SI-BONE’s pre-IPO backers included Redline Capital Management, Orbimed, Novo A/S, Skyline Ventures and Montreux Equity Partners.
17 October 2018•2 mins read
